The Endoscopic Submucosal Dissection Market was valued at USD 370.4 million in 2024, and is projected to reach USD 512.0 million by 2030, rising at a CAGR of 5.50%. The increasing prevalence of gastrointestinal cancers and other related disorders and advancements in endoscopic technology & instrumentation drive the demand for diagnostic and therapeutic procedures such as ESD. For instance, the American Cancer Society estimates that in 2024, there will be 26,890 new cases of stomach cancer, with 10,730 cases in women and 16,160 cases in men. As esophageal, gastric, and colorectal cancer rates continue to rise globally, the need for advanced procedures, such as ESD, is increasing.
Furthermore, the aging population worldwide is boosting the demand for ESD. As the global population ages, age-related gastrointestinal conditions, including cancers, are expected to rise. According to the American Cancer Society, gastric cancer predominantly affects older individuals, with an average age of 68 when diagnosed, and 6 out of 10 diagnosed annually are 65 or older. Many older patients also have other health conditions, which make traditional surgery riskier, further contributing to the rising demand for ESD procedures.
The development of high-definition endoscopes, improved electrosurgical knives, and enhanced imaging techniques have significantly increased the precision and safety of ESD procedures. These technological innovations have improved the efficacy of the treatment and expanded the indications for ESD, allowing it to be used for a broader range of lesions. Moreover, integrating artificial intelligence and machine learning in endoscopic procedures enhances diagnostic accuracy and procedural outcomes, further propelling market growth. For instance, in September 2024, Odin Medical Ltd. (Olympus Corporation company) obtained U.S. FDA 510(k) clearance for its CADDIE computer-aided detection (CADe). It is a cloud-based AI technology developed to help gastroenterologists to detect colorectal polyps during colonoscopy procedures.
The growing awareness and training programs for healthcare professionals in ESD techniques contribute to market growth. The proficiency of gastroenterologists and surgeons in ESD has been increasing, enhancing both the reach and feasibility of this advanced procedure, particularly in areas that previously had limited access to such treatments. Various medical organizations offer specialized training and certification programs, which are important in gaining knowledge and expertise in ESD. For instance, in April 2024, FUJIFILM Healthcare Europe GmbH introduced EndoGel, an innovative training model designed for performing Peroral Endoscopic Myotomy (POEM) and Endoscopic Submucosal Dissection (ESD) procedures. This simulator is available in two versions such as EndoGel for ESD/POEM and EndoGel for ESD. It is designed to be cost-effective for endoscopy professionals and healthcare institutions, aiming to enhance proficiency and patient outcomes through realistic simulation training.
This product will be delivered within 1-3 business days.
Furthermore, the aging population worldwide is boosting the demand for ESD. As the global population ages, age-related gastrointestinal conditions, including cancers, are expected to rise. According to the American Cancer Society, gastric cancer predominantly affects older individuals, with an average age of 68 when diagnosed, and 6 out of 10 diagnosed annually are 65 or older. Many older patients also have other health conditions, which make traditional surgery riskier, further contributing to the rising demand for ESD procedures.
The development of high-definition endoscopes, improved electrosurgical knives, and enhanced imaging techniques have significantly increased the precision and safety of ESD procedures. These technological innovations have improved the efficacy of the treatment and expanded the indications for ESD, allowing it to be used for a broader range of lesions. Moreover, integrating artificial intelligence and machine learning in endoscopic procedures enhances diagnostic accuracy and procedural outcomes, further propelling market growth. For instance, in September 2024, Odin Medical Ltd. (Olympus Corporation company) obtained U.S. FDA 510(k) clearance for its CADDIE computer-aided detection (CADe). It is a cloud-based AI technology developed to help gastroenterologists to detect colorectal polyps during colonoscopy procedures.
The growing awareness and training programs for healthcare professionals in ESD techniques contribute to market growth. The proficiency of gastroenterologists and surgeons in ESD has been increasing, enhancing both the reach and feasibility of this advanced procedure, particularly in areas that previously had limited access to such treatments. Various medical organizations offer specialized training and certification programs, which are important in gaining knowledge and expertise in ESD. For instance, in April 2024, FUJIFILM Healthcare Europe GmbH introduced EndoGel, an innovative training model designed for performing Peroral Endoscopic Myotomy (POEM) and Endoscopic Submucosal Dissection (ESD) procedures. This simulator is available in two versions such as EndoGel for ESD/POEM and EndoGel for ESD. It is designed to be cost-effective for endoscopy professionals and healthcare institutions, aiming to enhance proficiency and patient outcomes through realistic simulation training.
Global Endoscopic Submucosal Dissection Market Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global endoscopic submucosal dissection market report on the basis of product, indication, end use, and regions.Product Outlook (Revenue, USD Million, 2018-2030)
- Gastroscopes and Colonoscopes
- Knives
- Injection Agents
- Tissue Retractors
- Graspers/ Clips
- Other Products
Indication Outlook (Revenue, USD Million, 2018-2030)
- Stomach Cancer
- Colon Cancer
- Esophageal Cancer
End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals {Including inpatient departments and hospital outpatient departments (HOPDs)}
- Outpatient Facilities {Including ambulatory surgical centers (ASCs), clinics, and other outpatient care settings}
Regional Outlook (Revenue, USD Million, 2018-2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
This report addresses:
- Market intelligence to enable effective decision-making.
- Market estimates and forecasts from 2018 to 2030.
- Growth opportunities and trend analyses.
- Segment and regional revenue forecasts for market assessment.
- Competition strategy and market share analysis.
- Product innovation listings for you to stay ahead of the curve.
- COVID-19's impact and how to sustain in this fast-evolving market.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Endoscopic Submucosal Dissection Market Variables, Trends & Scope
Chapter 4. Endoscopic Submucosal Dissection Market Segment Analysis, by Product, 2018-2030 (USD Million)
Chapter 5. Endoscopic Submucosal Dissection Market Segment Analysis, by Indication, 2018-2030 (USD Million)
Chapter 6. Endoscopic Submucosal Dissection Market Segment Analysis, by End Use, 2018-2030 (USD Million)
Chapter 7. Endoscopic Submucosal Dissection Market Segment Analysis, by Region, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this Endoscopic Submucosal Dissection market report include:- Olympus Corporation
- Boston Scientific Corporation
- PENTAX Medical (Hoya Corporation)
- FUJIFILM Holdings Corporation
- Karl Storz GmbH & Co. KG
- Micro-Tech Endoscopy
- Medtronic
- CONMED Corporation
- STERIS plc.
- Cook Group
- Creo Medical
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 101 |
Published | February 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 370.4 Million |
Forecasted Market Value ( USD | $ 512 Million |
Compound Annual Growth Rate | 5.5% |
Regions Covered | Global |
No. of Companies Mentioned | 12 |